HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

BACKGROUND & AIMS: Significant scale-up of treatment among people who inject drugs (PWID) is crucial to achieve WHO HCV elimination targets. We explored the impact of on-site HCV diagnosis and treatment on PWID in an externalised hepatology clinic at the biggest harm reduction centre (HRC) in Ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Lens, Sabela, Miralpeix, Anna, Gálvez, Mont, Martró, Elisa, González, Noemi, Rodríguez-Tajes, Sergio, Mariño, Zoe, Saludes, Verónica, Reyes-Urueña, Juliana, Majó, Xavier, Colom, Joan, Forns, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617206/
https://www.ncbi.nlm.nih.gov/pubmed/36316992
http://dx.doi.org/10.1016/j.jhepr.2022.100580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617206/
https://www.ncbi.nlm.nih.gov/pubmed/36316992
http://dx.doi.org/10.1016/j.jhepr.2022.100580

Ejemplares similares